Sleep apnea and cardiovascular disease

Current Hypertension Reports

Volumn 12, Issue 3, 2010, Pages 182-188

  Logan, Alexander G ^a   Bradley, T Douglas ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Adaptive servo ventilation; Cardiovascular disease; Central sleep apnea; Continuous positive airway pressure; CPAP; Obstructive sleep apnea; Sleep apnea

Indexed keywords

ARTIFICIAL VENTILATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CENTRAL SLEEP APNEA SYNDROME; CLINICAL TRIAL; DAYTIME SOMNOLENCE; DISEASE SEVERITY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PROGNOSIS; REVIEW; RISK REDUCTION; SLEEP APNEA SYNDROME; STROKE; SURVIVAL; SYSTOLIC HEART FAILURE;

CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; HEALTH STATUS INDICATORS; HUMANS; POLYSOMNOGRAPHY; POSITIVE-PRESSURE RESPIRATION; PREVALENCE; RISK FACTORS; SLEEP APNEA, CENTRAL; SLEEP APNEA, OBSTRUCTIVE;

EID: 77956394614     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-010-0107-5     Document Type: Review

References (52)

1. Young T, Palta M, Dempsey J, et al.: The occurrence of sleepdisordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
2. Durán J, Esnaola S, Rubio R, Iztueta Á: Obstructive sleep apnea- hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001, 163:685-689.
3. Leung RST, Bradley TD: Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001, 164:2147-2165.
4. Smith SC Jr, Allen J, Blair SN, et al.: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation 2006, 113:2363-2372.
5. Jessup M, Abraham WT, Casey DE, et al.: 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults. Circulation 2009, 119:1977-2016.
6. U.S. Preventive Services Task Force: Using nontraditional risk factors in coronary heart disease risk assessment: U..S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009, 151:474-482.
7. Ryan CM, Floras JS, Logan AG, et al.: Shift of sleep apnoea type in heart failure patients in the CANPAP trial. Eur Respir J 2010, 35(3):592-597.
8. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999, 22:667-689.
9. Ellen RL, Marshall SC, Palayew M, et al.: Systematic review of motor vehicle crash risk in persons with sleep apnea. J Clin Sleep Med 2006, 2:193-200.
10. George CFP: Sleep apnea, alertness, and motor vehicle crashes. Am J Respir Crit Care Med 2007, 176:954-956.
11. Young T, Shahar E, Nieto FJ, et al.: Predictors of sleep-disordered breathing in community dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002, 162:893-900.
12. Bradley TD, Floras JS: Obstructive sleep apnea and its cardiovascular consequences. Lancet 2009, 373:82-93. This is a comprehensive review of the cardiovascular, cerebrovascular, and metabolic consequences that accompany OSA in conjunction with the mechanistic pathways implicated in mediating these effects.
13. Yumino D, Wang H, Floras JS, et al.: Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. J Cardiac Fail 2009, 15:279-285.
14. Owan TE, Redfield MM: Epidemiology of heart failure. Prog Cardiovasc Dis 2005, 47:320-332.
15. Bhatia RS, Tu JV, Lee DS, et al. : Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006, 355:260-269.
16. Bitter T, Faber L, Hering D, et al.: Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur J Heart Fail 2009, 11:602-608.
17. Arias MA, García-Río F, Alonso-Fernández A, et al.: Obstructive sleep apnea syndrome affects left ventricular diastolic function. Effects of nasal continuous positive airway pressure in men. Circulation 2005, 112:375-383.
18. Shahar E, Whitney CW, Redline S, et al.: Sleep-disordered breathing and cardiovascular disease. Am J Respir Crit Care Med 2001, 163:19-25.
19. Chami HA, Devereux RB, Gottdiener JS, et al.: Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health study. Circulation 2008, 117:2599- 2607.
20. Mehra R, Benjamin EJ, Shahar E, et al.: Association of nocturnal arrhythmias with sleep-disordered breathing. Am J Respir Crit Care Med 2006, 173:910-916.
21. Yaggi HK, Concato J, Kernan WN, et al.: Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005, 353: 2034-2041.
22. Peker Y, Hedner J, Kraiczi H, Loth S: Respiratory disturbance index. An independent predictor of mortality in coronary heart disease. Am J Respir Crit Care Med 2000, 162:81-86.
23. Yumino D, Tsurumi Y, Takagi A, et al.: Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 2007, 99:26-30.
24. Wang H, Parker JD, Newton GE, et al.: Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007, 49:1625-1631.
25. Yumino D, Wang H, Floras JS, et al.: Relationship between sleep apnoea and mortality in patients with ischaemic heart failure. Heart 2009, 95:819-824.
26. Floras JS: Sympathetic nervous system activation in human heart failure. J Am Coll Cardiol 2009, 54:375-385. This review integrates newer knowledge concerning mechanisms responsible for temporal, regional, and interindividual heterogeneity of sympathetic activation in human heart failure due to left ventricular systolic dysfunction.
27. Usui K, Parker JD, Newton GE, et al.: Left ventricular structural adaptations to obstructive sleep apnea in dilated cardiomyopathy. Am J Respir Crit Care Med 2006, 173:1170-1175.
28. Cargill RI, Kiely DG, Lipworth BJ: Adverse effects of hypoxaemia on diastolic filling in humans. Clin Sci (Lond) 1995, 89:165-169.
29. Mann DL, Bristow MR: Mechanisms and models in heart failure. The biomechanical model and beyond. Circulation 2005, 111:2837-2849.
30. Solin P, Bergin P, Richardson M, et al.: Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999, 99:1574-1579.
31. Kaneko Y, Floras JS, Usui K, et al.: Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003, 348:1233-1241.
32. Arzt M, Young T, Finn L, et al.: Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med 2006, 166:1716-1722.
33. Barbé F, Mayoralas LR, Duran J, et al.: Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. A randomized, controlled trial. Ann Intern Med 2001, 134:1015-1023.
34. Robinson GV, Smith DM, Langford BA, et al.: Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 2006, 27:1229-1235.
35. Arzt M, Bradley TD: Treatment of sleep apnea in heart failure. Am J Respir Crit Care Med 2006, 173:1300-1308.
36. Arzt M, Young T, Peppard PE, et al.: Dissociation of obstructive sleep apnea from hypersomnolence and obesity in patients with stroke. Stroke 2010, 41(3):e129-e134.
37. Friedman O, Logan AG: The price of obstructive sleep apnea- hypopnea: hypertension and other ill effects. Am J Hypertens 2009, 22:474-483.
38. Parati G, Lombardi C, Narkiewicz K: Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. Am J Physiol Regul Integr Comp Physiol 2007, 293(4):R1671-R1683.
39. Punjabi NM, Polotsky VY: Disorders of glucose metabolism in sleep apnea. J Appl Physiol 2005, 99:1998-2007.
40. Marin JM, Carrizo SJ, Vicente E, Agusti AG: Long-term cardiovascular outcomes in men with obstructive sleep apnoea- hypopnoea with or without treatment with continuous positive airway pressure; an observational study. Lancet 2005, 365:1046- 1053.
41. Doherty LS, Kiely JL, Swan V, McNicholas WT: Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005, 127:2076-2084.
42. Buchner NJ, Sanner BM, Borgel J, Rump LC: Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med 2007, 176:1274-1280.
43. Milleron O, Pillière R, Foucher A, et al.: Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004, 25:728-734.
44. Cuffe MS, Calii RM, Adams KF Jr, et al.: Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002, 287:1541-1547.
45. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K: Shortterm risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 2005, 293:1900-1905.
46. Bradley TD, Logan AG, Kimoff RJ, et al.: Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005, 353:2025-2033.
47. Arzt M, Floras JS, Logan AG, et al.: Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007, 115:3173-3180. This paper examines the uncertainties of CPAP treatment in heart failure patients with CSA and proposes new approaches to determine the safety and benefits of treating central apnea.
48. Johnson CB, Beanlands RS, Yoshinaga K, et al.: Acute and chronic effects of continuous positive airway pressure therapy on left ventricular systolic and diastolic function in patients with obstructive sleep apnea and congestive heart failure. Can J Cardiol 2008, 24:697-704.
49. Teschler H, Döhring J, Wang YM, Berthon-Jones M: Adaptive pressure support servo-ventilation: a novel treatment for Cheyne- Stokes respiration in heart failure. Am J Respir Crit Care Med 2001, 164:614-619.
50. Arzt M, Wensel R, Montalvan S, et al.: Effects of dynamic bilevel positive airway pressure support on central sleep apnea in men with heart failure. Chest 2008, 134:61-66.
51. Pepperell JC, Maskell NA, Jones DR, et al.: A randomized controlled trial of adaptive ventilation for Cheynes-Stokes breathing in heart failure. Am J Respir Crit Care Med 2003, 168:1109-1114.
52. Heron MP, Tejada-Vera B: Deaths: leading causes for 2005. National vital statistics reports; vol 58 no 08. Hyattsville, MD: National Center for Health Statistics. 2009. Accessed at www.cdc. gov/nchs/data/nvsr/nvsr58/nvsr58-08.pdf on 04 February 2010.